DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,940,595 | -18.1% | 6,026,128 | -20.3% | 0.01% | -25.0% |
| Q2 2023 | $90,265,237 | -60.6% | 7,559,903 | -55.9% | 0.01% | -20.0% |
| Q1 2023 | $229,220,166 | +18.3% | 17,144,366 | +90.4% | 0.01% | -47.4% |
| Q4 2022 | $193,729,724 | +10.0% | 9,002,311 | +2.4% | 0.02% | +5.6% |
| Q3 2022 | $176,093,000 | +44.1% | 8,791,491 | +28.8% | 0.02% | +50.0% |
| Q2 2022 | $122,196,000 | +374.8% | 6,826,574 | +163.1% | 0.01% | +500.0% |
| Q1 2022 | $25,737,000 | -46.0% | 2,594,519 | -8.3% | 0.00% | -50.0% |
| Q4 2021 | $47,692,000 | -7.0% | 2,830,353 | +30.9% | 0.00% | 0.0% |
| Q3 2021 | $51,303,000 | -2.6% | 2,161,909 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $52,655,000 | – | 2,312,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |